Baidu
map

移动医疗解决方案——卫生保健的未来

2016-02-25 sunshine编译 MedSci原创

移动医疗解决方案——卫生保健的未来纸质文件,电话访问或拜访收集并传达结果的时代过去了。现在,移动医疗操作系统的引入使得信息可以通过触摸屏幕来分享。随着移动医疗变得越来越普遍,其解决方案也正在激增。通过云计算,人们可以直接访问共享数据、资源和公共基础设施。在网络上,组织机构可为用户需求提供服务并执行任务,以满足不断变化的需求和标准。电子应用使得这些都成为了可能,特别是在医疗保健方面上。移动医疗,或m

纸质文件,电话访问或拜访收集并传达结果的时代过去了。现在,移动医疗操作系统的引入使得信息可以通过触摸屏幕来分享。随着移动医疗变得越来越普遍,其解决方案也正在激增。

通过云计算,人们可以直接访问共享数据、资源和公共基础设施。

在网络上,组织机构可为用户需求提供服务并执行任务,以满足不断变化的需求和标准。电子应用使得这些都成为了可能,特别是在医疗保健方面上。


图片来源:medicalnewstoday

移动医疗,或mHealth,整合了云计算技术和设备,如平板电脑、手机以及个人数码助手(PDAs)。但是它可使mHealth应用和医疗信息随时随地查看,而且它必须还能随身携带,安全且易于使用。

mHealth系统所支持的应用和服务的范围包括:

移动远程医疗,用于远程会诊
患者数据的存储和共享
机体重要脏器的个性化监测,现在可通过联网穿戴设备提高
基于位置的医疗服务以确保位置相关信息的传递
应急反应及管理
健康保健信息的普及。

但是随着移动技术的快速发展,所存在的限制可能会就是我们的想象力。

移动技术在医疗保健中的优势与挑战

随着政府和个人经受越来越大的压力来提高效率,mHealth解决方案或可为此提供很多的优势。

移动互联——无线系统,意味着它可以在任何地方使用,特别是在医疗保健区域。

相互合作可以减少错误发生的风险:纸面工作较少避免了医生的思路不清晰,并可减少两名医生作出不同的决定的风险。

移动现场保健数字工具可通过即时记录数据并可作为当时及未来可能的证据,有助于患者和专业人员的保护以避免诉讼纠纷的发生。

mHealth可通过即时记录信息并减少任务的重复从而可以节省时间和金钱。还可召开虚拟会议,从而避免了参会人员地理位置的限制及移动。

数据和资源的汇集可带来更紧密的合作,并创造出更强大的团队。由于研究、训练材料和其他新的东西的即时及在线分享使得专业的发展变得更加可行。

mHealth解决方案所面临的挑战包括数据存储与管理的实用性,对网络的可用性和维护,以及兼容性和互操作性。

最大的问题可能是安全和隐私,由此提出了一些问题:权限限制,数据匿名性和保密性,以及基础设施的完整性。

初始财政支出、培训以及组织内部的变革阻力或可在日后带来一些挑战。

例子:Medopad

Medopad是一种移动医疗操作系统(MHOS™),可提供软件、安全性、数据连通性以及更多的主要国家健康服务(NHS)医院等。

Medopad是一种设置还是一种APP?

Medopad的业务主管Jesko Bartelt解释道,Medopad并不是一种设置也不是一种APP,但是它提供了软件解决方案。

“Medopad是一种提供工作流程的移动医疗平台,可为医院和多个医疗机构提供整合且全面的患者信息。”

其他的功能,包括整合Apple Watch,以帮助癌症患者化疗的管理。

此外,还有一个谷歌眼镜的应用程序,允许外科医生手术中穿戴,可为培训项目展示手术程序,还可与其他不在手术室的专家会诊。

Medopad与现有的系统如何协作?

Bartelt解释道,通过手机医院数据库的数据并整合成一个中心资源,Medopad整合和补充了现有的医院系统。医生可通过iPad快速获得此信息。

其中一个功能可能是医生可拍摄患者表面的症状,并通过这个系统与其他可提供建议的专业人员共享。

Medopad如何处理患者数据?

Bartelt解释道,Medopad并不包含数据,但是它提供了一个范围广泛的医疗健康和患者数据。医生可以通过它来查看并补充患者的病历,获得实验室的结果,查看患者的生命体征,拍摄照片等。这个设备意味着医院可整合患者的数据,由此可“通过移动设备实时为医生提供信息。”

Bartelt解释道,“医生不再需要翻阅护士所标记的病历记录,Medopad可通过iPad为医生自动提供相关的病历。”

Apple Watch应用允许医生与其他患者联系,以为患者提供更好的支持,并最终提供更好的护理。

Medopad提供了哪些安全保障?

一项研究指出,mHealth的主要挑战是可确保IT基础设施的安全,可保护好患者的数据隐私。

要实现这一点,必须有效结合监管要求和技术创新。

为了发展medopad,除了获得CE认证作为一个医疗装置外,medopad还使用了来自金融部门的安全技术。虽然患者的数据可被无线传送,但是这些数据是受强加密保护的。

因为数据并不是存储在medopad中,由此也提高了数据的安全性。该系统只允许通过医院服务器来获取信息,因此只要医院服务器是安全的,那么数据就是安全的。

技术可以是完美的,但是行为和组织的问题也会影响数据的安全性,例如,哪些组织或卫生保健专业人员可获得mHealth数据以及可获得哪些数据集。

在这个系统内整个医疗团队都可以使用它,包括医生、护士和管理人员。每个病例中,个人卫生保健提供者都应决定谁应该使用这个数据。

“如果设备位于医院以外的地方,” Bartelt说道, “Medopad软件可启动自动清除功能,清除数据。”

世界各地,人口老龄化和预算的减少给医疗保健系统和专业人士带来了很大的压力。

mHealth解决方案或通过适应当地需求以其灵活的方式来缓解这些压力。

通过监测斯里兰卡偏远地区的心脏病患者的生命体征,远在美国度假的医生也可调整患者的心脏药物,mHealth解决方案将重塑我们的医疗保健体验。

原始出处:

Yvette Brazier. mHealth solutions: the future of health care. Tuesday 23 February 2016

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1987981, encodeId=c648198e98197, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun May 01 06:56:00 CST 2016, time=2016-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771641, encodeId=8e031e7164176, content=<a href='/topic/show?id=1d503660007' target=_blank style='color:#2F92EE;'>#卫生保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36600, encryptionId=1d503660007, topicName=卫生保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054b38331488, createdName=minlingfeng, createdTime=Sat Jun 04 03:56:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530460, encodeId=be5315304606a, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sat Feb 27 07:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65747, encodeId=8eb865e470b, content=可靠吗,医疗事故如何解决, beContent=null, objectType=article, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Fri Feb 26 13:10:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65735, encodeId=e4e665e353a, content=发现趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Feb 26 11:19:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65713, encodeId=b81065e1391, content=期待中, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 26 08:36:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65711, encodeId=21cd65e11dc, content=有搞头, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 08:33:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65673, encodeId=0c75656e370, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Thu Feb 25 23:49:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65647, encodeId=b7b76564e14, content=一场革命, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Feb 25 18:52:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65640, encodeId=510865640d9, content=前景, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 18:28:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1987981, encodeId=c648198e98197, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun May 01 06:56:00 CST 2016, time=2016-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771641, encodeId=8e031e7164176, content=<a href='/topic/show?id=1d503660007' target=_blank style='color:#2F92EE;'>#卫生保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36600, encryptionId=1d503660007, topicName=卫生保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054b38331488, createdName=minlingfeng, createdTime=Sat Jun 04 03:56:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530460, encodeId=be5315304606a, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sat Feb 27 07:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65747, encodeId=8eb865e470b, content=可靠吗,医疗事故如何解决, beContent=null, objectType=article, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Fri Feb 26 13:10:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65735, encodeId=e4e665e353a, content=发现趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Feb 26 11:19:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65713, encodeId=b81065e1391, content=期待中, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 26 08:36:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65711, encodeId=21cd65e11dc, content=有搞头, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 08:33:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65673, encodeId=0c75656e370, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Thu Feb 25 23:49:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65647, encodeId=b7b76564e14, content=一场革命, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Feb 25 18:52:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65640, encodeId=510865640d9, content=前景, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 18:28:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1987981, encodeId=c648198e98197, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun May 01 06:56:00 CST 2016, time=2016-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771641, encodeId=8e031e7164176, content=<a href='/topic/show?id=1d503660007' target=_blank style='color:#2F92EE;'>#卫生保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36600, encryptionId=1d503660007, topicName=卫生保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054b38331488, createdName=minlingfeng, createdTime=Sat Jun 04 03:56:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530460, encodeId=be5315304606a, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sat Feb 27 07:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65747, encodeId=8eb865e470b, content=可靠吗,医疗事故如何解决, beContent=null, objectType=article, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Fri Feb 26 13:10:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65735, encodeId=e4e665e353a, content=发现趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Feb 26 11:19:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65713, encodeId=b81065e1391, content=期待中, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 26 08:36:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65711, encodeId=21cd65e11dc, content=有搞头, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 08:33:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65673, encodeId=0c75656e370, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Thu Feb 25 23:49:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65647, encodeId=b7b76564e14, content=一场革命, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Feb 25 18:52:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65640, encodeId=510865640d9, content=前景, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 18:28:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
    2016-02-27 yahu
  4. [GetPortalCommentsPageByObjectIdResponse(id=1987981, encodeId=c648198e98197, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun May 01 06:56:00 CST 2016, time=2016-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771641, encodeId=8e031e7164176, content=<a href='/topic/show?id=1d503660007' target=_blank style='color:#2F92EE;'>#卫生保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36600, encryptionId=1d503660007, topicName=卫生保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054b38331488, createdName=minlingfeng, createdTime=Sat Jun 04 03:56:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530460, encodeId=be5315304606a, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sat Feb 27 07:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65747, encodeId=8eb865e470b, content=可靠吗,医疗事故如何解决, beContent=null, objectType=article, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Fri Feb 26 13:10:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65735, encodeId=e4e665e353a, content=发现趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Feb 26 11:19:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65713, encodeId=b81065e1391, content=期待中, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 26 08:36:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65711, encodeId=21cd65e11dc, content=有搞头, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 08:33:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65673, encodeId=0c75656e370, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Thu Feb 25 23:49:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65647, encodeId=b7b76564e14, content=一场革命, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Feb 25 18:52:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65640, encodeId=510865640d9, content=前景, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 18:28:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
    2016-02-26 jiangxianchen

    可靠吗,医疗事故如何解决

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1987981, encodeId=c648198e98197, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun May 01 06:56:00 CST 2016, time=2016-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771641, encodeId=8e031e7164176, content=<a href='/topic/show?id=1d503660007' target=_blank style='color:#2F92EE;'>#卫生保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36600, encryptionId=1d503660007, topicName=卫生保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054b38331488, createdName=minlingfeng, createdTime=Sat Jun 04 03:56:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530460, encodeId=be5315304606a, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sat Feb 27 07:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65747, encodeId=8eb865e470b, content=可靠吗,医疗事故如何解决, beContent=null, objectType=article, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Fri Feb 26 13:10:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65735, encodeId=e4e665e353a, content=发现趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Feb 26 11:19:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65713, encodeId=b81065e1391, content=期待中, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 26 08:36:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65711, encodeId=21cd65e11dc, content=有搞头, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 08:33:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65673, encodeId=0c75656e370, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Thu Feb 25 23:49:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65647, encodeId=b7b76564e14, content=一场革命, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Feb 25 18:52:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65640, encodeId=510865640d9, content=前景, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 18:28:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
    2016-02-26 xingyong

    发现趋势

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1987981, encodeId=c648198e98197, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun May 01 06:56:00 CST 2016, time=2016-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771641, encodeId=8e031e7164176, content=<a href='/topic/show?id=1d503660007' target=_blank style='color:#2F92EE;'>#卫生保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36600, encryptionId=1d503660007, topicName=卫生保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054b38331488, createdName=minlingfeng, createdTime=Sat Jun 04 03:56:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530460, encodeId=be5315304606a, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sat Feb 27 07:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65747, encodeId=8eb865e470b, content=可靠吗,医疗事故如何解决, beContent=null, objectType=article, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Fri Feb 26 13:10:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65735, encodeId=e4e665e353a, content=发现趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Feb 26 11:19:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65713, encodeId=b81065e1391, content=期待中, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 26 08:36:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65711, encodeId=21cd65e11dc, content=有搞头, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 08:33:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65673, encodeId=0c75656e370, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Thu Feb 25 23:49:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65647, encodeId=b7b76564e14, content=一场革命, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Feb 25 18:52:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65640, encodeId=510865640d9, content=前景, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 18:28:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
    2016-02-26 dhzzm

    期待中

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1987981, encodeId=c648198e98197, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun May 01 06:56:00 CST 2016, time=2016-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771641, encodeId=8e031e7164176, content=<a href='/topic/show?id=1d503660007' target=_blank style='color:#2F92EE;'>#卫生保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36600, encryptionId=1d503660007, topicName=卫生保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054b38331488, createdName=minlingfeng, createdTime=Sat Jun 04 03:56:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530460, encodeId=be5315304606a, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sat Feb 27 07:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65747, encodeId=8eb865e470b, content=可靠吗,医疗事故如何解决, beContent=null, objectType=article, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Fri Feb 26 13:10:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65735, encodeId=e4e665e353a, content=发现趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Feb 26 11:19:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65713, encodeId=b81065e1391, content=期待中, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 26 08:36:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65711, encodeId=21cd65e11dc, content=有搞头, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 08:33:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65673, encodeId=0c75656e370, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Thu Feb 25 23:49:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65647, encodeId=b7b76564e14, content=一场革命, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Feb 25 18:52:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65640, encodeId=510865640d9, content=前景, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 18:28:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
    2016-02-26 wei834766788

    有搞头

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1987981, encodeId=c648198e98197, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun May 01 06:56:00 CST 2016, time=2016-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771641, encodeId=8e031e7164176, content=<a href='/topic/show?id=1d503660007' target=_blank style='color:#2F92EE;'>#卫生保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36600, encryptionId=1d503660007, topicName=卫生保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054b38331488, createdName=minlingfeng, createdTime=Sat Jun 04 03:56:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530460, encodeId=be5315304606a, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sat Feb 27 07:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65747, encodeId=8eb865e470b, content=可靠吗,医疗事故如何解决, beContent=null, objectType=article, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Fri Feb 26 13:10:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65735, encodeId=e4e665e353a, content=发现趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Feb 26 11:19:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65713, encodeId=b81065e1391, content=期待中, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 26 08:36:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65711, encodeId=21cd65e11dc, content=有搞头, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 08:33:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65673, encodeId=0c75656e370, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Thu Feb 25 23:49:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65647, encodeId=b7b76564e14, content=一场革命, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Feb 25 18:52:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65640, encodeId=510865640d9, content=前景, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 18:28:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
    2016-02-25 sanshengshi

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=1987981, encodeId=c648198e98197, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun May 01 06:56:00 CST 2016, time=2016-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771641, encodeId=8e031e7164176, content=<a href='/topic/show?id=1d503660007' target=_blank style='color:#2F92EE;'>#卫生保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36600, encryptionId=1d503660007, topicName=卫生保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054b38331488, createdName=minlingfeng, createdTime=Sat Jun 04 03:56:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530460, encodeId=be5315304606a, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sat Feb 27 07:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65747, encodeId=8eb865e470b, content=可靠吗,医疗事故如何解决, beContent=null, objectType=article, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Fri Feb 26 13:10:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65735, encodeId=e4e665e353a, content=发现趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Feb 26 11:19:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65713, encodeId=b81065e1391, content=期待中, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 26 08:36:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65711, encodeId=21cd65e11dc, content=有搞头, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 08:33:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65673, encodeId=0c75656e370, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Thu Feb 25 23:49:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65647, encodeId=b7b76564e14, content=一场革命, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Feb 25 18:52:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65640, encodeId=510865640d9, content=前景, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 18:28:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
    2016-02-25 xiaotaiyang1

    一场革命

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=1987981, encodeId=c648198e98197, content=<a href='/topic/show?id=446a91002d6' target=_blank style='color:#2F92EE;'>#解决方案#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91002, encryptionId=446a91002d6, topicName=解决方案)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Sun May 01 06:56:00 CST 2016, time=2016-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1771641, encodeId=8e031e7164176, content=<a href='/topic/show?id=1d503660007' target=_blank style='color:#2F92EE;'>#卫生保健#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36600, encryptionId=1d503660007, topicName=卫生保健)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=054b38331488, createdName=minlingfeng, createdTime=Sat Jun 04 03:56:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530460, encodeId=be5315304606a, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Sat Feb 27 07:56:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65747, encodeId=8eb865e470b, content=可靠吗,医疗事故如何解决, beContent=null, objectType=article, channel=null, level=null, likeNumber=217, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6KcicAVC1MwuHfSLw3PzIKiaSnTBUuAtRkrrxWpibukl35iciaGtBq4LYQv4ian1tPC3IdmzWI2dZ3cDC8wUg5CnBxlJ/0, createdBy=33a51675735, createdName=jiangxianchen, createdTime=Fri Feb 26 13:10:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65735, encodeId=e4e665e353a, content=发现趋势, beContent=null, objectType=article, channel=null, level=null, likeNumber=236, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f7111664586, createdName=xingyong, createdTime=Fri Feb 26 11:19:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65713, encodeId=b81065e1391, content=期待中, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=387d1660055, createdName=dhzzm, createdTime=Fri Feb 26 08:36:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65711, encodeId=21cd65e11dc, content=有搞头, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=078f1661649, createdName=wei834766788, createdTime=Fri Feb 26 08:33:00 CST 2016, time=2016-02-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65673, encodeId=0c75656e370, content=赞, beContent=null, objectType=article, channel=null, level=null, likeNumber=169, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cab51623450, createdName=sanshengshi, createdTime=Thu Feb 25 23:49:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65647, encodeId=b7b76564e14, content=一场革命, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90f31612316, createdName=xiaotaiyang1, createdTime=Thu Feb 25 18:52:00 CST 2016, time=2016-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=65640, encodeId=510865640d9, content=前景, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK29w9r0upRgxUXHNhe7bd3VxHnhBSpibMbKOjtX92zXr78SkuZfUNuADrjHiaw6uibZaEYjh9cJLzew/132, createdBy=261e1682638, createdName=1de3b290m83(暂无匿称), createdTime=Thu Feb 25 18:28:00 CST 2016, time=2016-02-25, status=1, ipAttribution=)]
    2016-02-25 1de3b290m83(暂无匿称)

    前景

    0

相关资讯

盘点2015年度移动医疗领域十大关键词

2014年可以说是移动医疗的元年,2015年是移动医疗的变革年。这一年注定不平凡,会在中国医疗史上留下浓浓一笔!2015年上半年可以说是移动医疗的上半场 ,到夏天达到顶峰,而2015年下半年,其实,大家都认为已进行移动医疗的下半场。也意味着2015年一年,对于移动医疗而言,是过山车!从风口到凡间,冷暖难自知。具体也可以说是从mHealth向cHealth迈进,前者强调的外在形式---移动,而后者则

众说:学习美国移动医疗绝不能照搬

在医患供需严重不匹配的市场,医生用户才是移动医疗业务最重要的资源和价值来源。 美国的移动医疗一直以来都是中国移动医疗学习的标杆,最近一年一度的移动医疗大会mHealth移动医疗峰会在美国召开,中美间移动医疗间的差异再次成为话题热点。在过去的2014年中,美国医疗行业输出在GDP占18%,中国去年只占5.3%左右,可以看出中国医疗市场蕴藏着的巨大潜力。究竟美国的移动医疗成功的秘诀在于哪里?而中

协和余可谊:移动医疗浪潮中的医生角色

可在关注余可谊大夫微信号:dryukeyi 沃伦.巴菲特曾经说过,“我们在这样的经济环境里工作,在战场上挽救他人生命的人获得的回报是一枚勋章,在教学工作中做得出色的老师获得的回报是家长的感谢信,而那些会炒股的人获得的回报却是数以亿计的财富。” 我们医生面对移动医疗的大潮可能会心情澎湃,这恐怕是我们获取财富的巨大机会。是的,这恐怕是一次千载难逢的机会,因为医疗健康领域有太多的地方

全球炫酷的流动手术中心要开张了,但是它根本不像一个医院!

纪念斯隆-凯特琳癌症中心(Memorial Sloan Kettering Cancer Center,MSKCC)是世界上历史最悠久、规模最大的私立癌症中心。《美国新闻与世界报道》在公布的2014~2015年癌症专科评选中,MSKCC是全美排名第一的癌症中心。今年1月,MSK花3亿美元建造的最先进的门诊手术中心,乔西·罗伯逊手术中心(Josie Robertson Surgery Center,

欧姆龙(Omron)发布新款血压计 更像智能手表

血压测量通常需要在医生的帮助下进行,但欧姆龙却希望你可以随时随地都可以自行测量血压。这家日本厂商在本届CES展上带来了两款血压计,和同类型设备相比,它们使用起来要更加方便。 这两款血压计名叫Project Zero,使用者无需医生指导就能用它们来测量血压。两款设备分别是臂带式和腕带式,后者看上去更像是一部普通的智能手表,而非笨重的医疗设备。 通常来讲,在手腕上测量血压比较麻烦,你的

打车软件医疗**战,Uber为何胜,滴滴为何败

滴滴打车一个多月前试水医疗的惨败仍在眼前,大洋彼岸却传来了Uber健康一战成功的消息。滴滴和Uber有很多相似之处,他们进军医疗的打法也很相似,用车把医护人员送到用户家里,提供“按需”(on demand)医疗服务。所以分析他们成功和失败的原因,恐怕对很多移动医疗企业有借鉴意义。“滴滴医生”和Uber健康的相同之处,大家都知道,不多说了。甚至两家都有赠送给用户的小礼物,滴滴赠送阿里健康药箱,Ube

Baidu
map
Baidu
map
Baidu
map